CRX - good times ahead

JJ I concur with your interpretation of cash flow positive being for part of, rather than the whole of, the reporting period. I'm looking for confirmation of revenue growth around 25% from H1 to H2 in the prelims, which should give a reduction in operating losses from 500k to 200k. This will go some way to reduce cashburn.

At 30 June 2005 cash in hand was 1.3m but we don't know how much will be spent in H2 on product offering, state-of-the-art laboratory facilities and office reorganisation but the Interims did state that "Existing operations are considered to have sufficient resources to fund their own expansion going forward."

There has been steady selling of the share for a few months now so time will tell.